Etoricoxib: Difference between revisions
From SEHK Wiki
| Line 28: | Line 28: | ||
===Administration in hepatic impairment=== | ===Administration in hepatic impairment=== | ||
Mild hepatic impairment: 60 mg once daily | Mild hepatic impairment: 60 mg once daily | ||
Moderate hepatic impairment: 60 mg every other day or 30 mg once daily. | Moderate hepatic impairment: 60 mg every other day or 30 mg once daily. | ||
Etoricoxib should not be given to patients with severe hepatic impairment. | Etoricoxib should not be given to patients with severe hepatic impairment. | ||
Revision as of 23:49, 28 September 2020
Catergory: Etoricoxib
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Arcoxia Tablet 120 mg | P1S1S3 |
Mechanism of Action
Anti-inflammatory agent, Non-steroidal anti-inflammatory drug (NSAID) Selective COX-2 inhibitor
Dosage
For osteoarthritis
Oral: 30 mg daily once daily, increased to 60 mg once daily if necessary.
For rheumatoid arthritis and ankylosing spondylitis
Oral: 60 mg once daily, increased to 90 mg once daily if necessary.
For gouty arthritis
Oral: 120 mg once daily. Such higher doses should only be used for acute symptomatic period and for a maximum of 8 days.
For postoperative dental pain
Oral: 90 mg once daily for a maximum of 3 days.
Administration in hepatic impairment
Mild hepatic impairment: 60 mg once daily
Moderate hepatic impairment: 60 mg every other day or 30 mg once daily.
Etoricoxib should not be given to patients with severe hepatic impairment.
